M
Michael P. Barnes
Researcher at Newcastle University
Publications - 63
Citations - 3070
Michael P. Barnes is an academic researcher from Newcastle University. The author has contributed to research in topics: Rehabilitation & Botulinum toxin. The author has an hindex of 22, co-authored 60 publications receiving 2820 citations.
Papers
More filters
Journal ArticleDOI
A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity
Anand Pandyan,Garth R. Johnson,Christopher Price,Richard Curless,Michael P. Barnes,Helen Rodgers +5 more
TL;DR: The application of both scales would suggest that confusion exists on their characteristics and limitations as measures of spasticity, and there is a need to standardize methods to apply these scales in clinical practice and research.
Journal ArticleDOI
Spasticity: Clinical perceptions, neurological realities and meaningful measurement
Anand Pandyan,M. Gregoric,Michael P. Barnes,D.E. Wood,F. van Wijck,Jane Burridge,Hermanus J. Hermens,Garth R. Johnson +7 more
TL;DR: The aim of this paper is to review briefly the understanding of the phenomenon of spasticity based in current evidence based on current evidence.
Journal ArticleDOI
Rehabilitation after traumatic brain injury.
TL;DR: This chapter outlines some basic concepts of rehabilitation and emphasises the importance of valid and reliable outcome measures.
Journal ArticleDOI
BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A
Lisa Shaw,Helen Rodgers,C Price,van, Wijck, F,Phil Shackley,Nick Steen,Michael P. Barnes,Gary A. Ford,Laura Graham,Investigators BoTULS +9 more
TL;DR: The evidence of botulinum toxin type A plus therapy being cost-effective for a range of societal willingness to pay for a QALY values is presented and cost-effectiveness acceptability curves are presented.
Journal ArticleDOI
Spasticity in Multiple Sclerosis
TL;DR: Spasticity is highly prevalent in the MS population and is significantly associated with a reduced level of functional independence, and the need for further information and education to health professionals and to people with MS is highlighted.